These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6812403)

  • 1. Use of radionuclide ventriculography for assessment of changes in myocardial performance induced by disopyramide phosphate.
    Kowey PR; Friedman PL; Podrid PJ; Zielonka J; Lown B; Wynne J; Holman BL
    Am Heart J; 1982 Oct; 104(4 Pt 1):769-74. PubMed ID: 6812403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of disopyramide on left ventricular function: assessment by radionuclide cineangiography.
    Gottdiener JS; Dibianco R; Bates R; Sauerbrunn BJ; Fletcher RD
    Am J Cardiol; 1983 May; 51(9):1554-8. PubMed ID: 6405606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral disopyramide therapy on left ventricular function.
    Greene AC; Iskandrian AS; Hakki AH; Kane SA; Segal BL
    Chest; 1983 Mar; 83(3):480-4. PubMed ID: 6825481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold infarction areas of varying size in the presence of left ventricular dysfunction: the impact on left ventricular ejection fraction determination by gated SPECT compared to radionuclide ventriculography.
    Canbaz F; Basoglu T; Semirgin SU; Yapici O; Yazici M
    Hell J Nucl Med; 2005; 8(3):149-53. PubMed ID: 16390019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on ventricular function of disopyramide, procainamide and quinidine as determined by radionuclide angiography.
    Wisenberg G; Zawadowski AG; Gebhardt VA; Prato FS; Goddard MD; Nichol PM; Rechnitzer PA; Gryfe-Becker B
    Am J Cardiol; 1984 May; 53(9):1292-7. PubMed ID: 6711431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular collapse associated with disopyramide therapy.
    Desai JM; Scheinman MM; Hirschfeld D; Gonzalez R; Peters RW
    Chest; 1981 May; 79(5):545-51. PubMed ID: 7226932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disopyramide-induced ventricular fibrillation.
    Nicholson WJ; Martin CE; Gracey JG; Knoch HR
    Am J Cardiol; 1979 May; 43(5):1053-5. PubMed ID: 433766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disopyramide-induced ventricular tachycardia.
    Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
    Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinidine effects due to disopyramide.
    Frieden J
    N Engl J Med; 1978 Apr; 298(17):975. PubMed ID: 642984
    [No Abstract]   [Full Text] [Related]  

  • 10. Disopyramide.
    Morady F; Scheinman MM; Desai J
    Ann Intern Med; 1982 Mar; 96(3):337-43. PubMed ID: 7036817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of the negative inotropic effect of disopyramide.
    Kenedi PP
    J Int Med Res; 1988; 16(4):257-63. PubMed ID: 3169371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hypoglycemia associated with disopyramide.
    Nappi JM; Dhanani S; Lovejoy JR; VanderArk C
    West J Med; 1983 Jan; 138(1):95-7. PubMed ID: 6404062
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial perfusion defects with near-to-absent count reduction: a comparison of gated SPECT to radionuclide ventriculography in the determination of left ventricular function.
    Canbaz F; Basoglu T; Yapici O; Aygul S; Yazici M
    Int J Cardiovasc Imaging; 2006 Apr; 22(2):231-41. PubMed ID: 16261279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias.
    Paulk EA
    Angiology; 1987 Feb; 38(2 Pt 2):198-204. PubMed ID: 3103494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
    Dhurandhar RW; Nademanee K; Goldman AM
    Heart Lung; 1978; 7(5):783-7. PubMed ID: 250503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congestive heart failure caused by oral disopyramide.
    Podrid PJ; Schoeneberger A; Lown B
    N Engl J Med; 1980 Mar; 302(11):614-7. PubMed ID: 7351909
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiogenic shock and disopyramide phosphate.
    Story JR; Abdulla AM; Frank MJ
    JAMA; 1979 Aug; 242(7):654-5. PubMed ID: 449005
    [No Abstract]   [Full Text] [Related]  

  • 19. Disopyramide induced atypical ventricular tachycardia.
    Chia BL
    Aust N Z J Med; 1980 Dec; 10(6):665-8. PubMed ID: 6938189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
    Pouleur H; Chaudron JM; Reyns P
    Eur J Cardiol; 1977 Jul; 5(5):397-404. PubMed ID: 330168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.